Abstract
PurposeThis purpose of this study is to look at the availability of routine antenatal anti‐D prophylaxis (RAADP) in the maternity units within the North‐west Deanery, England five years after the publication of this technology appraisal guideline (no. 41) by the National Institute for Clinical Excellence (NICE).Design/methodology/approachAntenatal clinics of all the major 18 maternity hospitals were contacted about their existing practice on RAADP. Responses were obtained by facsimile and telephone.FindingsA total of 11 of the 18 units had implemented the practice between April 2003 and May 2007. Some had changed their practice from two doses to a single dose on the grounds of logistics. Cost appeared to be the most important reason in non‐user units. The practice is under consideration in two units.Practical implicationsThere may be difficulty in universal implementation of NICE guidelines despite the supporting evidence.Originality/valueThis study demonstrates the issue of difficulty of local health economies in supporting national guidelines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
